Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

Dubai: At Arab Health 2025 in Dubai, Emirates Health Services (EHS) is showcasing initiatives advancing heart and diabetes treatments. The first project is the Total Artificial Heart (TAH), developed ...

Emirates Health Services EHS takes centre stage at Arab Health 2025 medical expo showcasing a series of groundbreaking ...

DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...

President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...